通向先进疫苗之路：流感案例研究。
Roads to advanced vaccines: influenza case study.
机构信息
Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, D-38124, Braunschweig, Germany.
出版信息
Microb Biotechnol. 2017 Sep;10(5):1036-1040. doi: 10.1111/1751-7915.12835. Epub 2017 Aug 15.
Abstract
Vaccines represent a cornerstone to ensure healthy lives and promote well-being for all at all ages. However, there are many diseases for which vaccines are not available, are relatively ineffective or need to be adapted periodically. Advances in microbial biotechnology will contribute to overcoming these roadblocks by laying the groundwork for improving and creating new approaches for developing better vaccines, as illustrated here in the case of influenza.
摘要
疫苗是确保所有人在所有年龄段都能健康生活和促进健康的基石。然而，仍有许多疾病尚无疫苗可用，或者疫苗相对低效，或者需要定期进行调整。微生物生物技术的进步将有助于克服这些障碍，为改进和创造新方法开发更好的疫苗奠定基础，正如这里流感案例所展示的那样。
相似文献
1
Roads to advanced vaccines: influenza case study.通向先进疫苗之路：流感案例研究。
Microb Biotechnol. 2017 Sep;10(5):1036-1040. doi: 10.1111/1751-7915.12835. Epub 2017 Aug 15.
2
Special Issue-Immunity to Influenza Viruses.特刊-流感病毒免疫。
Viruses. 2022 Feb 3;14(2):319. doi: 10.3390/v14020319.
3
Vaccination strategies for an influenza pandemic.流感大流行的疫苗接种策略。
J Infect Dis. 2005 Apr 15;191(8):1207-9. doi: 10.1086/428952. Epub 2005 Mar 14.
4
Influenza vaccines: challenges and solutions.流感疫苗：挑战与解决方案。
Cell Host Microbe. 2015 Mar 11;17(3):295-300. doi: 10.1016/j.chom.2015.02.012.
5
[Live cold-adapted influenza vaccine: state-of-the-art].[减毒活流感疫苗：最新进展]
Vopr Virusol. 2011 Jan-Feb;56(1):4-17.
6
Seasonal influenza vaccine policy, use and effectiveness in the tropics and subtropics - a systematic literature review.热带和亚热带地区的季节性流感疫苗政策、使用情况及有效性——一项系统文献综述
Influenza Other Respir Viruses. 2016 Jul;10(4):254-67. doi: 10.1111/irv.12374. Epub 2016 May 26.
7
Immunogenicity and protective efficacy of replication-incompetent influenza virus-like particles.复制缺陷型流感病毒样颗粒的免疫原性和保护效力
J Virol. 2002 Jan;76(2):767-73. doi: 10.1128/jvi.76.2.767-773.2002.
8
Slowing Influenza Virus Evolution: A Role for Multiple Synergistic Antiviral Specificities in Vaccination Strategies.减缓流感病毒进化：多种协同抗病毒特异性在疫苗接种策略中的作用
Viral Immunol. 2020 Apr;33(3):197-200. doi: 10.1089/vim.2019.0167.
9
Challenges of Making Effective Influenza Vaccines.制作有效流感疫苗的挑战。
Annu Rev Virol. 2020 Sep 29;7(1):495-512. doi: 10.1146/annurev-virology-010320-044746. Epub 2020 May 11.
10
[Validity of anti-influenza vaccination].[抗流感疫苗接种的有效性]
Clin Ter. 1983 Jan 31;104(2):151-7.
引用本文的文献
1
Using the Past to Maximize the Success Probability of Future Anti-Viral Vaccines.利用过去经验最大化未来抗病毒疫苗的成功概率
Vaccines (Basel). 2020 Oct 1;8(4):566. doi: 10.3390/vaccines8040566.
2
Next Generation Influenza Vaccines: Looking into the Crystal Ball.下一代流感疫苗：展望未来
Vaccines (Basel). 2020 Aug 21;8(3):464. doi: 10.3390/vaccines8030464.
本文引用的文献
1
Heterologous prime-boost vaccination with H3N2 influenza viruses of swine favors cross-clade antibody responses and protection.用猪源H3N2流感病毒进行异源初免-加强免疫有利于跨分支抗体反应和保护作用。
NPJ Vaccines. 2017;2. doi: 10.1038/s41541-017-0012-x. Epub 2017 Apr 20.
2
Factors affecting immune responses to the influenza vaccine.影响流感疫苗免疫反应的因素。
Hum Vaccin Immunother. 2018 Mar 4;14(3):637-646. doi: 10.1080/21645515.2017.1338547. Epub 2017 Jul 21.
3
Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012-2013 and 2013-2014.2012 - 2013年及2013 - 2014年期间，高剂量与标准剂量流感疫苗在美国医疗保险受益人群中预防流感后死亡的比较效果
J Infect Dis. 2017 Feb 15;215(4):510-517. doi: 10.1093/infdis/jiw641.
4
Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis.MF59佐剂季节性流感疫苗在老年人中的有效性：一项系统评价和荟萃分析。
Vaccine. 2017 Jan 23;35(4):513-520. doi: 10.1016/j.vaccine.2016.12.011. Epub 2016 Dec 23.
5
Immunosenescence-Related Transcriptomic and Immunologic Changes in Older Individuals Following Influenza Vaccination.流感疫苗接种后老年个体中与免疫衰老相关的转录组学和免疫学变化
Front Immunol. 2016 Nov 2;7:450. doi: 10.3389/fimmu.2016.00450. eCollection 2016.
6
Viral vector-based influenza vaccines.基于病毒载体的流感疫苗。
Hum Vaccin Immunother. 2016 Nov;12(11):2881-2901. doi: 10.1080/21645515.2016.1210729. Epub 2016 Jul 25.
7
New Horizons in the Development of Novel Needle-Free Immunization Strategies to Increase Vaccination Efficacy.新型无针免疫策略发展以提高疫苗接种效果的新视野。
Curr Top Microbiol Immunol. 2016;398:207-234. doi: 10.1007/82_2016_495.
8
Development of a stable liquid formulation of live attenuated influenza vaccine.减毒活流感疫苗稳定液体制剂的研发。
Vaccine. 2016 Jul 12;34(32):3676-83. doi: 10.1016/j.vaccine.2016.04.074. Epub 2016 May 4.
9
Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events.佐剂甲型H1N1流感疫苗接种揭示了年龄依赖性早期反应和临床不良事件的淋巴细胞特征。
Nat Immunol. 2016 Feb;17(2):204-13. doi: 10.1038/ni.3328. Epub 2016 Jan 4.
10
Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures.跨多年及不同人群的流感疫苗接种免疫的系统分析揭示了共同的分子特征。
Immunity. 2015 Dec 15;43(6):1186-98. doi: 10.1016/j.immuni.2015.11.012.
Zotero 插件